Andrew R Zullo1,2, Tingting Zhang1, Geetanjoli Banerjee1,3, Yoojin Lee1, Kevin W McConeghy1,2, Douglas P Kiel4,5, Lori A Daiello1, Vincent Mor1, Sarah D Berry4,5. 1. Department of Health Services, Policy, and Practice, School of Public Health, Brown University, Providence, Rhode Island. 2. Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, Rhode Island. 3. Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island. 4. Department of Medicine, Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. 5. Institute for Aging Research, Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Abstract
OBJECTIVES: To quantify the variation in hip fracture incidence across U.S. nursing home (NH) facilities and states and examine how hip fracture incidence varies according to facility- and state-level characteristics. DESIGN: Retrospective cohort using linked national Minimum Data Set assessments; Online Survey, Certification and Reporting records; and Medicare claims. SETTING: U.S. NHs with 100 or more beds. PARTICIPANTS: Long-stay NH residents between May 1, 2007, and April 30, 2008, from 1,481 facilities and 46 U.S. states (N = 201,892). MEASUREMENTS: Incident hip fractures were ascertained using Medicare Part A diagnostic codes. Each resident was followed for up to 2 years. RESULTS: The mean adjusted incidence rate of hip fractures for all facilities was 3.13 (95% confidence interval (CI) = 3.01-3.26) per 100 person-years (range 1.20, 95% CI = 1.15-1.26 to 6.40, 95% CI = 6.07-6.77). Facilities with the highest rates of hip fracture had greater percentages of residents taking psychoactive medications (top tertile 27.2%, bottom tertile 24.8%), and fewer nursing (top tertile 3.43, bottom tertile 3.53) and direct care (top tertile 3.22, bottom tertile 3.29) hours per day per resident. The combination of state and facility characteristics explained 6.7% of the variation in hip fracture, and resident characteristics explained 7.6%. CONCLUSION: Much of the variation in hip fracture incidence remained unexplained, although these findings indicate that potentially modifiable state and facility characteristics such as psychoactive drug prescribing and minimum staffing requirements could be addressed to help reduce the rate of hip fracture in U.S. NHs.
OBJECTIVES: To quantify the variation in hip fracture incidence across U.S. nursing home (NH) facilities and states and examine how hip fracture incidence varies according to facility- and state-level characteristics. DESIGN: Retrospective cohort using linked national Minimum Data Set assessments; Online Survey, Certification and Reporting records; and Medicare claims. SETTING: U.S. NHs with 100 or more beds. PARTICIPANTS: Long-stay NH residents between May 1, 2007, and April 30, 2008, from 1,481 facilities and 46 U.S. states (N = 201,892). MEASUREMENTS: Incident hip fractures were ascertained using Medicare Part A diagnostic codes. Each resident was followed for up to 2 years. RESULTS: The mean adjusted incidence rate of hip fractures for all facilities was 3.13 (95% confidence interval (CI) = 3.01-3.26) per 100 person-years (range 1.20, 95% CI = 1.15-1.26 to 6.40, 95% CI = 6.07-6.77). Facilities with the highest rates of hip fracture had greater percentages of residents taking psychoactive medications (top tertile 27.2%, bottom tertile 24.8%), and fewer nursing (top tertile 3.43, bottom tertile 3.53) and direct care (top tertile 3.22, bottom tertile 3.29) hours per day per resident. The combination of state and facility characteristics explained 6.7% of the variation in hip fracture, and resident characteristics explained 7.6%. CONCLUSION: Much of the variation in hip fracture incidence remained unexplained, although these findings indicate that potentially modifiable state and facility characteristics such as psychoactive drug prescribing and minimum staffing requirements could be addressed to help reduce the rate of hip fracture in U.S. NHs.
Authors: W A Ray; J A Taylor; K G Meador; P B Thapa; A K Brown; H K Kajihara; C Davis; P Gideon; M R Griffin Journal: JAMA Date: 1997-08-20 Impact factor: 56.272
Authors: Geetanjoli Banerjee; Andrew R Zullo; Sarah D Berry; Yoojin Lee; Kevin McConeghy; Doug P Kiel; Vincent Mor Journal: J Am Med Dir Assoc Date: 2016-07-25 Impact factor: 4.669
Authors: Andrew R Zullo; Tingting Zhang; Yoojin Lee; Kevin W McConeghy; Lori A Daiello; Douglas P Kiel; Vincent Mor; Sarah D Berry Journal: J Am Geriatr Soc Date: 2018-12-21 Impact factor: 5.562
Authors: Andrew R Zullo; Matthew Olean; Sarah D Berry; Yoojin Lee; Jennifer Tjia; Michael A Steinman Journal: J Gerontol A Biol Sci Med Sci Date: 2019-07-12 Impact factor: 6.053
Authors: Andrew R Zullo; Mark N Sorial; Yoojin Lee; Christine W Lary; Douglas P Kiel; Sarah D Berry Journal: J Am Geriatr Soc Date: 2019-10-03 Impact factor: 5.562
Authors: Jacob N Hunnicutt; Anne L Hume; Shao-Hsien Liu; Christine M Ulbricht; Jennifer Tjia; Kate L Lapane Journal: Drugs Aging Date: 2018-10 Impact factor: 3.923
Authors: Tingting Zhang; Ira B Wilson; Andrew R Zullo; David J Meyers; Yoojin Lee; Lori A Daiello; Dae Hyun Kim; Douglas P Kiel; Theresa I Shireman; Sarah D Berry Journal: J Am Med Dir Assoc Date: 2021-09-25 Impact factor: 7.802
Authors: Elliott Bosco; Andrew R Zullo; Kevin W McConeghy; Patience Moyo; Robertus van Aalst; Ayman Chit; Vincent Mor; Stefan Gravenstein Journal: Open Forum Infect Dis Date: 2019-05-15 Impact factor: 3.835